Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
FDAReview.org
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Monthly Archives: March 2019
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Raymond March
-
March 28, 2019
0
Generic Insulin Now Available After Nearly One Hundred Years of Regulatory...
Raymond March
-
March 25, 2019
0
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?
Raymond March
-
March 14, 2019
0
FDA Panel Backs Ketamine-Based Treatment for Depression
Raymond March
-
March 1, 2019
0
